Financial News

Alkermes Shares Immuno Oncology Clinical Trial Research

SOURCE: Alkermes


We are pleased to share clinical trial data on our investigational #immunooncology therapy and are excited to be a part of the 17th EADO Congress and 2021 World Mobile Congress Interactive Virtual Meeting.

Tweet me: .@Alkermes is pleased to share clinical trial data on their investigational #immunooncology therapy at the 17th EADO Congress and #WMC21 Interactive Virtual Meeting.

KEYWORDS: NASDAQ:ALKS, Alkermes, Immuno-Oncology, 17th EADO Congress, 2021 World Mobile Congress Interactive Virtual Meeting

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info